You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Express Scripts
Johnson and Johnson
McKinsey
Dow

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CELEXA

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Celexa

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00018902 Treatment of SSRI-Resistant Depression In Adolescents (TORDIA) Completed National Institute of Mental Health (NIMH) Phase 2/Phase 3 2001-01-01 The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
NCT00018902 Treatment of SSRI-Resistant Depression In Adolescents (TORDIA) Completed University of Pittsburgh Phase 2/Phase 3 2001-01-01 The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.
NCT00044798 Magnetic Stimulation Therapy for Treating Vascular Depression Completed National Institute of Mental Health (NIMH) Phase 3 2001-09-01 This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).
NCT00044798 Magnetic Stimulation Therapy for Treating Vascular Depression Completed University of Iowa Phase 3 2001-09-01 This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Celexa

Condition Name

Condition Name for Celexa
Intervention Trials
Depression 10
Major Depressive Disorder 10
Healthy 3
Major Depression 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Celexa
Intervention Trials
Depression 24
Depressive Disorder 22
Depressive Disorder, Major 14
Disease 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Celexa

Trials by Country

Trials by Country for Celexa
Location Trials
United States 95
Canada 5
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Celexa
Location Trials
California 12
New York 11
Massachusetts 7
Pennsylvania 7
Ohio 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Celexa

Clinical Trial Phase

Clinical Trial Phase for Celexa
Clinical Trial Phase Trials
Phase 4 13
Phase 3 5
Phase 2/Phase 3 3
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Celexa
Clinical Trial Phase Trials
Completed 32
Recruiting 4
Unknown status 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Celexa

Sponsor Name

Sponsor Name for Celexa
Sponsor Trials
National Institute of Mental Health (NIMH) 19
New York State Psychiatric Institute 6
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Celexa
Sponsor Trials
Other 40
NIH 28
Industry 7
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Mallinckrodt
Baxter
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.